Search

Search Constraints

You searched for: Author/Creator Iveson, Tim

Search Results

2. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Issue 5 (May 2019)

3. COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study. (November 2022)

4. Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study. Issue 18 (20th June 2022)

5. Outcomes and survival following neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus: Inverse propensity score weighted analysis. Issue 12 (December 2020)

6. Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer. Issue 1 (28th November 2020)

7. Second-line FOLFOX chemotherapy for advanced biliary tract cancer – Authors' reply. Issue 7 (July 2021)

8. Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial. Issue 5 (May 2021)

9. Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study. Issue 6 (June 2022)